This is one of those times. An entity called Tutanota is offering only $65 a share for Merck stock, and will only buy up to one million shares.
The rub is that Merck common stock is trading at nearly $100 on the New York Stock Exchange as of Friday afternoon, and will likely open very near $100 on Monday morning.
So if you're thinking about selling, use the New York Stock Exchange, your E*TRADE account or your favorite broker. Do not transfer your shares into this deceptively priced mini tender. Here's the latest on it all:
. . .Tutanota LLC (Tutanota) has commenced an unsolicited “mini-tender” offer, dated November 10, 2025, to purchase up to 1,000,000 shares of Merck common stock at $65.00 per share. The offer price is approximately 24.66% below the closing price of Merck common stock on November 7, 2025 ($86.28), the last trading day before the date of the offer, and approximately 31.56% below the closing price of Merck common stock on November 20, 2025 ($94.97), the day prior to this release.
Merck does not endorse Tutanota’s offer and recommends that Merck shareholders reject the offer and not tender their shares in response to Tutanota’s unsolicited mini-tender offer. This mini-tender offer is at a price below the closing price for Merck’s shares (as of the day prior to this release) and is subject to numerous conditions, including Tutanota’s ability to obtain financing. Merck is not associated in any way with Tutanota, its mini-tender offer or the offer documentation. . . .
Now you know, and stay bundled up against the cold tonight. . . and hope for a win. I know I will. I've got all my ski gear with me! Grin!
नमस्ते
No comments:
Post a Comment